Ligne de temps

Philippe Souque
Ingénieur(e) de Recherche
01 janv. 2023
publication

Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.

Lire plus
14 sept. 2022
publication

A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.

Lire plus
26 juil. 2022
publication

A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.

Lire plus
07 déc. 2021
publication

Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.

Lire plus
04 janv. 2021
publication

Clustering and reverse transcription of HIV-1 genomes in nuclear niches of macrophages.

Lire plus
01 janv. 2021
publication

High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.

Lire plus
16 déc. 2020
publication

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.

Lire plus
02 sept. 2020
publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Lire plus
01 sept. 2020
publication

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

Lire plus